Get the Stockscreener App
11.38
2.99%
0.33
Angiodynamic Inc stock is traded at $11.38, with a volume of 499.65K.
It is up +2.99% in the last 24 hours and down -27.42% over the past month.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
See More
Previous Close:
$11.05
Open:
$11.05
24h Volume:
499.65K
Relative Volume:
0.37
Market Cap:
$478.58M
Revenue:
$320.17M
Net Income/Loss:
$-36.74M
P/E Ratio:
-12.85
EPS:
-0.8856
Net Cash Flow:
$-2.86M
1W Performance:
+1.34%
1M Performance:
-27.42%
6M Performance:
+10.06%
1Y Performance:
-3.80%
1-Day Range:
$11.05
$11.52
1-Week Range:
$10.62
$11.97
52-Week Range:
$9.39
$16.29
Angiodynamic Inc Stock (ANGO) Company Profile
Name
Angiodynamic Inc
Sector
Industry
Phone
(518) 798-1215
Address
14 PLAZA DRIVE, LATHAM
Compare ANGO vs ISRG, BDX, RMD, ALC, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANGO
Angiodynamic Inc
|
11.38 | 478.58M | 320.17M | -36.74M | -2.86M | -0.8856 |
ISRG
Intuitive Surgical Inc
|
426.28 | 150.60B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
192.66 | 52.48B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
241.63 | 33.98B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
66.72 | 32.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.63 | 32.14B | 29.14B | 1.07B | 1.05B | 1.1956 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-16-25 | Initiated | Lake Street | Buy |
| Apr-05-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Sep-25-23 | Initiated | H.C. Wainwright | Buy |
| Apr-17-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-15-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-20-21 | Initiated | Oppenheimer | Perform |
| Nov-25-20 | Upgrade | Raymond James | Mkt Perform → Strong Buy |
| Apr-08-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-01-19 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-03-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-05-18 | Downgrade | Craig Hallum | Buy → Hold |
| Apr-07-17 | Reiterated | Cantor Fitzgerald | Overweight |
| Mar-30-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| Feb-08-17 | Initiated | Barclays | Equal Weight |
| Nov-04-16 | Initiated | Cantor Fitzgerald | Buy |
| Apr-08-16 | Resumed | Piper Jaffray | Neutral |
| Jan-08-16 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-24-15 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-19-14 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-09-12 | Reiterated | Canaccord Genuity | Hold |
| Jun-25-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jul-15-11 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jul-15-11 | Upgrade | Stifel Nicolaus | Hold → Buy |
| Jun-14-11 | Downgrade | Wedbush | Neutral → Underperform |
| Sep-08-10 | Reiterated | Wedbush | Neutral |
View All
Angiodynamic Inc Stock (ANGO) Latest News
ANGO Q1 Earnings Beat Estimates on Med Tech Growth, Revenues Up Y/Y - Zacks Investment Research
AngioDynamics (ANGO) Reports Q1 Loss, Lags Revenue Estimates - Zacks Investment Research
ANGIODYNAMICS Q1 2027 Earnings Preview: Recent $ANGO Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
AngioDynamics, Inc. (ANGO) Stock Price, News, Quote & History - Yahoo! Finance Canada
A Bronx hospital won a research award to test if scans can predict clot-removal success. - Stock Titan
A successor's appointment could set the CEO's retirement date at AngioDynamics (ANGO). There's another trigger. - Stock Titan
AngioDynamics Fiscal 2026 Net Loss Widens to $36.7 Million - Minichart
Sales reached $320.2 million at AngioDynamics (ANGO). Five executives received cash bonuses. - Stock Titan
AngioDynamics, Inc. (ANGO) stock price, news, quote and history - Yahoo Finance UK
AngioDynamics to Report Fiscal 2027 First Quarter Results on October 8, 2026 - Yahoo Finance Australia
AngioDynamics to Report Fiscal 2027 First Quarter Results on October 8, 2026 - Yahoo Finance
AngioDynamics, Inc. expected to post a loss of 11 cents a shareEarnings Preview - TradingView
How Angiodynamics Inc. (ANGO) Affects Rotational Strategy Timing - Stock Traders Daily
AngioDynamics Inc. (ANGO) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
387,188 Shares in AngioDynamics, Inc. $ANGO Bought by Western Standard LLC - MarketBeat
AngioDynamics (ANGO) Up 8.9% Since Last Earnings Report: Can It Continue? - Yahoo Finance
AngioDynamics, Inc. (ANGO) Presents at Canaccord Genuity's 46th Annual Growth ConferenceSlideshow - Seeking Alpha
AngioDynamics, Inc. (ANGO) Stock Analysis: Uncovering a 32% Potential Upside with Robust Buy Ratings - DirectorsTalk Interviews
AngioDynamics SmartPort Infection Lawsuit Alleges Defective Port Caused Sepsis - aboutlawsuits.com
AngioDynamics, Inc. $ANGO Shares Purchased by Lazard Asset Management LLC - MarketBeat
Senior Vice President of Regulatory Affairs Warren Nighan Sold A Bunch Of Shares In AngioDynamics - simplywall.st
Segall Bryant & Hamill LLC Trims Stock Position in AngioDynamics, Inc. $ANGO - MarketBeat
AngioDynamics, Inc. (NASDAQ:ANGO) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
AngioDynamics (ANGO) SVP Warren Nighan Jr. sells 23,370 shares at $14.72 - Stock Titan
AngioDynamics (NASDAQ: ANGO) insider plans $344K sale of equity awards - Stock Titan
AngioDynamics Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Live webcast set for AngioDynamics' Aug. 11 presentation - Stock Titan
AngioDynamics Inc (ANGO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AngioDynamics, Inc. Revenue Breakdown – NASDAQ:ANGO - TradingView
AngioDynamics Inc. (ANGO) SVP receives 8,047 shares, 4,506 withheld for tax - Stock Titan
AngioDynamics (NASDAQ: ANGO) executive settles 20,052 performance units - Stock Titan
AngioDynamics (NASDAQ: ANGO) CEO settles performance share grant - Stock Titan
AngioDynamics Inc (ANGO) CFO performance shares vest, tax withheld - Stock Titan
AngioDynamics (ANGO) SVP receives shares from PSU vesting, with tax withholding - Stock Titan
Form 4 AngioDynamics Inc For: 22 July By Investing.com - Investing.com Canada
AngioDynamics (ANGO) director receives 11,887-share stock award - Stock Titan
AngioDynamics Inc. (ANGO) awards 17,966 RSUs and performance rights - Stock Titan
ETFs Investing in AngioDynamics, Inc. Stocks - TradingView
AngioDynamics Inc (ANGO) director awarded 11,887 shares in annual grant - stocktitan.net
AngioDynamics (ANGO) SVP uses 8,228 shares to cover RSU tax obligations - Stock Titan
AngioDynamics (ANGO) CFO withholds 12,067 shares to satisfy RSU tax obligations - Stock Titan
AngioDynamics (ANGO) SVP covers tax obligations through share withholding - Stock Titan
AngioDynamics: NanoKnife Momentum Looks Real, But Much Of The Good News Is Priced In - Seeking Alpha
AngioDynamics, Inc. $ANGO Shares Bought by Bastion Asset Management Inc. - marketbeat.com
AngioDynamics: Growth Is Working, Price Knows It (Rating Downgrade) - Seeking Alpha
H.C. Wainwright raises AngioDynamics stock price target on growth - investing.com
AngioDynamics Q4 Earnings Beat Estimates, Gross Margin Expands - TradingView
AngioDynamics Q4 Earnings Beat Estimates, Gross Margin Expands - Yahoo Finance
AngioDynamics, Inc. Q4 2026 Earnings Call Summary - Yahoo Finance
ANGIODYNAMICS INC FY 2026: Revenue $320.17M, EPS ($0.88) — 10-K Summary - TradingView
Angiodynamic Inc Stock (ANGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Angiodynamic Inc Stock (ANGO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| WARREN NIGHAN | Officer |
Jul 30 '26 |
Proposed Sale |
14.72 |
23,370 |
344,004 |
0 |
| Piccinini Laura | SVP International |
Jul 22 '26 |
Option Exercise |
0.00 |
8,047 |
0 |
86,435 |
| Nighan Warren JR | SVP Quality and Regulatory |
Jul 22 '26 |
Option Exercise |
0.00 |
5,694 |
0 |
89,786 |
| Trowbridge Stephen A | EVP and CFO |
Jul 22 '26 |
Option Exercise |
0.00 |
16,296 |
0 |
314,115 |
| Clemmer James C | President and CEO |
Jul 22 '26 |
Option Exercise |
0.00 |
52,358 |
0 |
889,176 |
| Campbell Chad Thomas | SVP/GM, Vascular Access |
Jul 22 '26 |
Option Exercise |
0.00 |
6,466 |
0 |
111,006 |
| Weiss Lawrence T | SVP, Chief Legal Officer |
Oct 21 '25 |
Buy |
11.81 |
10,000 |
118,100 |
93,597 |
| Trowbridge Stephen A | EVP and CFO |
Oct 13 '25 |
Buy |
11.16 |
890 |
9,932 |
256,629 |
| Clemmer James C | President and CEO |
Oct 09 '25 |
Buy |
11.15 |
10,000 |
111,500 |
882,529 |
4.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):